Jan 17 - ARGS - 6 Signs of Bullish Breakout in coming weeks
#1 - (Black Lines) Triple Bottom starting back on Nov. 2.
#2 - (Orange Line) Rising Support Trend also from the beginning of November.
#3 - (Red Lines) Short term support and resistance trending upward since mid December.
#4 - (Blue Line) Successful Bear Trap resulting in "double bottom" with open at 0.155
#5 - (Grey Line) 8 Month Falling Wedge meeting Support in coming month.
#6 - High potential for catalysts in coming months.
Possible Catalysts by End of January to assist this breakout:
1.) Update from NASDAQ meeting held this month (as to whether an extension to April will be given).
Possible Catalysts by March:
2.) Update regarding FDA Amendment that was sought after regarding Feb 2017 decision to discontinue trial. This news might take sometime depending on results / urgency.
Possible Catalysts anticipated by April to May:
3.) Preliminary results for ARGS-003 and ARGS-004 trials.
4.) Today 3 CTO requests were submitted - Obviously very speculative but thats a lot of financial information that wants to be withheld.
#2 - (Orange Line) Rising Support Trend also from the beginning of November.
#3 - (Red Lines) Short term support and resistance trending upward since mid December.
#4 - (Blue Line) Successful Bear Trap resulting in "double bottom" with open at 0.155
#5 - (Grey Line) 8 Month Falling Wedge meeting Support in coming month.
#6 - High potential for catalysts in coming months.
Possible Catalysts by End of January to assist this breakout:
1.) Update from NASDAQ meeting held this month (as to whether an extension to April will be given).
Possible Catalysts by March:
2.) Update regarding FDA Amendment that was sought after regarding Feb 2017 decision to discontinue trial. This news might take sometime depending on results / urgency.
Possible Catalysts anticipated by April to May:
3.) Preliminary results for ARGS-003 and ARGS-004 trials.
4.) Today 3 CTO requests were submitted - Obviously very speculative but thats a lot of financial information that wants to be withheld.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.